United States Securities and Exchange Commission · EDGAR Accession 0002090859-26-000006

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-36869
Issuer CIK 2090859
Raising via StartEngine Primary, LLC

Barricade Therapeutics Corp.

CorporationDEIncorporated 2017Fort Worth, TXbarricadetherapeutics.com
Nature of amendmentUpdating Form C financial information section and Extending to June 29 2026
A

The Offering

as disclosed in this filing
Other (Convertible Note)
$20,000
$1,235,000
June 29, 2026
15 days remaining
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Revenue +224% YoYBurn decreasingDebt / assets 840%1 employee
Line itemMost recent FYPrior FYΔ
Revenue810,102249,853▲ 224%
Cost of goods sold00
Net income(436,817)(935,689)▲ burn
Total assets507,84976,373▲ 565%
Cash & equivalents504,87210,832
Accounts receivable00
Short-term debt863,301433,544▲ 99%
Long-term debt3,402,6692,969,312▲ 15%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36869 · all filings under this campaign
Loading campaign history…